EQUINOX/ SI0031117813 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
16:04
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
05/06
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
03/06
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
23/05
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
17/05
Lowey Dannenberg Notifies EQUINIX, INC. (“Equinix” or the “Company”) (NASDAQ: EQIX) Investors of Sec...
GlobeNewswire
16/05
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
14/05
Navios Maritime Partners L.P. Reports Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire
08/05
EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporat...
GlobeNewswire
06/05
EyePoint Pharmaceuticals Announces Topline Data from the Phase 2 PAVIA Trial of DURAVYU™ in Non-Prol...
GlobeNewswire
02/05
Martinrea International Inc. Reports Strong First Quarter Results and Declares Dividend
GlobeNewswire
23/04
Equinox Gold Consolidates Ownership of the Greenstone Gold Mine Arranges Term Loan and Bought Deal E...
GlobeNewswire
16/04
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
02/04
EyePoint Pharmaceuticals Expands Scientific Advisory Board with World-Renowned Retina Specialists
GlobeNewswire
18/03
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
07/03
EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights ...
GlobeNewswire
04/03
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Offic...
GlobeNewswire
29/02
EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2...
GlobeNewswire
16/02
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
15/02
Minelab Showcases Its Newest Technologies at the 50th Anniversary IWA Outdoor Classics in Germany